| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193117 | Annals of Allergy, Asthma & Immunology | 2008 | 4 Pages |
Abstract
In patients with PAR, the SAC state is more prevalent compared with the healthy population. Topical nasal mupirocin reduces the SAC state but fails to clinically improve PAR, as assessed by the SS.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Y MD, Z MD, A PhD, M MD, M MD, M MD, E MD,